Who owns Kyverna Therapeutics, Inc.?
- Ticker: KYTX
- CUSIP Number: 501976104
Tip: Access positions for across all investors
Analyze quarterly positions in Kyverna Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Kyverna Therapeutics stock
Who bought or sold Kyverna Therapeutics, Inc. this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Gilead Sciences | 4.1M | $36M | 0% | Mar 2026 |
|
| Bain Capital Life Sciences Investors | 3.1M | $27M | 0% | Mar 2026 |
|
| AIGH Capital Management | 2.0M | $17M | 33% | Mar 2026 |
|
| Deerfield Management Company | 2.0M | $17M | 0% | Mar 2026 |
|
| Vanguard Capital Management | 1.8M | $15M | 100% | Mar 2026 |
|
| Vanguard Group | 1.8M | $17M | 35% | Dec 2025 |
|
| Adage Capital Partners GP | 1.7M | $16M | 100% | Dec 2025 |
|
| Balyasny Asset Management | 1.1M | $9.7M | 15% | Mar 2026 |
|
| Millennium Management | 1.0M | $8.7M | 69% | Mar 2026 |
|
| Insight Holdings | 989k | $8.5M | 0% | Mar 2026 |
|
| Morgan Stanley | 977k | $8.4M | -3% | Mar 2026 |
|
| BlackRock | 877k | $7.6M | 61% | Mar 2026 |
|
| Woodline Partners | 845k | $7.3M | 0% | Mar 2026 |
|
| D. E. Shaw & Co | 722k | $6.2M | 39% | Mar 2026 |
|
| Propel Bio Management | 644k | $5.6M | -3% | Mar 2026 |
|
| Mbb Public Markets I | 615k | $5.3M | 0% | Mar 2026 |
|
| UBS Group | 450k | $3.9M | 122% | Mar 2026 |
|
| Geode Capital Management | 424k | $3.7M | 59% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 412k | $3.6M | 63% | Mar 2026 |
|
| Susquehanna International | 292k | $2.7M | 17% | Dec 2025 |
|
| Heights Capital Management | 272k | $2.6M | 100% | Dec 2025 |
|
| Vanguard Fiduciary Trust | 225k | $1.9M | 100% | Mar 2026 |
|
| Point72 Asset Management | 223k | $1.9M | 593% | Mar 2026 |
|
| Goldman Sachs Group | 213k | $1.8M | 59% | Mar 2026 |
|
| Burkehill Global Management | 200k | $1.7M | 0% | Mar 2026 |
|
| Invesco | 187k | $1.6M | 100% | Mar 2026 |
|
| Two Sigma Investments | 182k | $1.6M | -12% | Mar 2026 |
|
| Renaissance Technologies | 178k | $1.7M | 8% | Dec 2025 |
|
| Bridgeway Capital Management | 175k | $1.6M | 0% | Dec 2025 |
|
| Simplify Asset Management | 173k | $1.5M | -10% | Mar 2026 |
|
| TD Asset Management | 169k | $1.5M | -24% | Mar 2026 |
|
| Barclays | 165k | $1.5M | 116% | Dec 2025 |
|
| Squarepoint Ops | 147k | $1.3M | 6% | Mar 2026 |
|
| Maven Securities | 146k | $1.4M | 100% | Dec 2025 |
|
| Marshall Wace | 136k | $1.3M | 100% | Dec 2025 |
|
| Manufacturers Life Insurance Company | 135k | $1.2M | 0% | Mar 2026 |
|
| Stifel Financial | 131k | $1.1M | 4% | Mar 2026 |
|
| Charles Schwab Investment Management | 125k | $1.2M | 0% | Dec 2025 |
|
| Jane Street | 120k | $1.0M | -52% | Mar 2026 |
|
| Y-Intercept | 115k | $991k | 100% | Mar 2026 |
|
| Wells Fargo & Company | 114k | $987k | 53% | Mar 2026 |
|
| Wesbanco Trust And Investments | 110k | $952k | 100% | Mar 2026 |
|
| Kera Capital Partners | 108k | $933k | -18% | Mar 2026 |
|
| State Street Corporation | 91k | $858k | 0% | Dec 2025 |
|
| Citadel Advisors | 88k | $756k | -75% | Mar 2026 |
|
| 683 Capital Management | 85k | $734k | -26% | Mar 2026 |
|
| Jump Financial | 80k | $755k | 100% | Dec 2025 |
|
| Dimensional Fund Advisors | 78k | $677k | 0% | Mar 2026 |
|
| Hudson Bay Capital Management | 71k | $613k | -20% | Mar 2026 |
|
| Qube Research & Technologies | 64k | $598k | 73% | Dec 2025 |
|
| Brevan Howard Capital Management | 64k | $548k | 100% | Mar 2026 |
|
| Quadrature Capital | 57k | $539k | 100% | Dec 2025 |
|
| Bank of America Corporation | 56k | $481k | 100% | Mar 2026 |
|
| Man Group | 54k | $462k | 100% | Mar 2026 |
|
| Nano Cap New Millennium Growth Fund | 54k | $503k | 100% | Dec 2025 |
|
| Northern Trust | 52k | $485k | 0% | Dec 2025 |
|
| American Century Companies | 46k | $436k | 44% | Dec 2025 |
|
| Ing Investment Management | 44k | $380k | -35% | Mar 2026 |
|
| Citigroup | 42k | $365k | 100% | Mar 2026 |
|
| Peapod Lane Capital | 40k | $337k | -78% | Mar 2026 |
|
| Walleye Trading Advisors | 38k | $330k | 100% | Mar 2026 |
|
| Banque Cantonale Vaudoise | 31k | $263k | 100% | Mar 2026 |
|
| ACT Capital Management | 30k | $259k | 20% | Mar 2026 |
|
| Raymond James Financial | 25k | $236k | 100% | Dec 2025 |
|
| Leucadia National Corporation | 24k | $206k | -25% | Mar 2026 |
|
| XTX Topco | 23k | $219k | -53% | Dec 2025 |
|
| ADAR1 Capital Management | 22k | $194k | -61% | Mar 2026 |
|
| Federated Investors | 21k | $179k | 0% | Mar 2026 |
|
| Schonfeld Strategic Advisors | 20k | $174k | -30% | Mar 2026 |
|
| Phoenix Wealth Advisors | 20k | $171k | 61% | Mar 2026 |
|
| Caxton | 19k | $162k | 0% | Mar 2026 |
|
| JustInvest | 19k | $162k | -2% | Mar 2026 |
|
| Cambria Investment Management | 18k | $169k | 100% | Dec 2025 |
|
| Jacobs Levy Equity Management | 17k | $143k | -85% | Mar 2026 |
|
| GSA Capital Partners | 16k | $139k | 100% | Mar 2026 |
|
| Diametric Capital | 16k | $139k | 100% | Mar 2026 |
|
| Vanguard Global Advisers | 15k | $129k | 100% | Mar 2026 |
|
| OMERS Administration Corporation | 15k | $128k | -57% | Mar 2026 |
|
| Canada Pension Plan Investment Board | 14k | $120k | 100% | Mar 2026 |
|
| Graham Capital Management | 12k | $103k | 100% | Mar 2026 |
|
| Ethic | 12k | $103k | -5% | Mar 2026 |
|
| Fox Run Management | 11k | $84k | 100% | Mar 2026 |
|
| China Universal Asset Management | 10k | $88k | 42% | Mar 2026 |
|
| EntryPoint Capital | 10k | $95k | 100% | Dec 2025 |
|
| GSB Wealth Management | 10k | $86k | 100% | Mar 2026 |
|
| Capital Advisors | 10k | $86k | 0% | Mar 2026 |
|
| FMR | 7.0k | $66k | -12% | Dec 2025 |
|
| Tower Research Capital | 5.1k | $48k | -19% | Dec 2025 |
|
| Deutsche Bank Aktiengesellschaft | 3.9k | $34k | 0% | Mar 2026 |
|
| Advisor Group Holdings | 3.2k | $30k | 29% | Dec 2025 |
|
| Mirae Asset Global Investments | 3.0k | $26k | 40% | Mar 2026 |
|
| Royal Bank of Canada | 2.5k | $28k | 26% | Mar 2026 |
|
| Caitong International Asset Management | 2.1k | $18k | 100% | Mar 2026 |
|
| Zurcher Kantonalbank | 1.6k | $14k | 100% | Mar 2026 |
|
| Pnc Financial Services | 1.5k | $13k | -8% | Mar 2026 |
|
| Russell Investments | 1.3k | $11k | 0% | Mar 2026 |
|
| Gf Fund Management | 977.00 | $8.4k | 14% | Mar 2026 |
|
| Quantbot Technologies | 822.00 | $7.1k | 100% | Mar 2026 |
|
| National Bank Of Canada /fi/ | 400.00 | $3.8k | 100% | Dec 2025 |
|
| NISA Investment Advisors | 301.00 | $2.6k | 0% | Mar 2026 |
|
| TFC Financial Management | 300.00 | $2.6k | 0% | Mar 2026 |
|
| CWM | 263.00 | $2.0k | -47% | Dec 2025 |
|
| Fourth Dimension Wealth | 250.00 | $2.2k | 0% | Mar 2026 |
|
| EverSource Wealth Advisors | 135.00 | $1.2k | -17% | Mar 2026 |
|
| Fortitude Family Office | 126.00 | $1.1k | 100% | Mar 2026 |
|
| Jones Financial Companies, L.L | 37.00 | $347.999800 | 100% | Dec 2025 |
|
| SRS Capital Advisors | 11.00 | $95.000400 | 0% | Mar 2026 |
|
Who sold out of Kyverna Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Alyeska Investment Group | Dec 2025 | 600k | $5.6M |
| RFG Advisory | Dec 2025 | 445k | $4.2M |
| Monashee Investment Management | Dec 2025 | 195k | $1.8M |
| Two Sigma Advisers | Dec 2025 | 49k | $464k |
| Springbok Capital Management | Sep 2025 | 19k | $117k |
| Quest Partners | Dec 2025 | 16k | $154k |
| DekaBank Deutsche Girozentrale | Dec 2025 | 7.5k | $197k |
| Jpmorgan Chase & Co | Sep 2025 | 6.7k | $40k |
| Ohio Pers | Sep 2025 | 4.6k | $28k |
| Vermillion & White Wealth Management Group | Dec 2025 | 1.1k | $10k |
| Advisory Services Network | Sep 2025 | 86.00 | $516.000000 |
| Parallel Advisors | Dec 2025 | 26.00 | $243.999600 |
| SBI Securities | Dec 2025 | 22.00 | $207.000200 |